Kyle Mach is a partner in the San Francisco office of Munger, Tolles & Olson who focuses his practice on complex antitrust matters.
Mr. Mach has extensive experience litigating antitrust cases, including many high-profile matters and jury trials throughout the United States. For example, Mr. Mach was a key member of the trial team in Steves & Sons v. JELD-WEN, which secured Steves & Sons the first ever divestiture remedy awarded a private plaintiff under Section 7 of the Clayton Act. Mr. Mach also has extensive experience with complex antitrust issues arising in the pharmaceutical industry; for example, representing Solvay Pharmaceuticals, Inc. in defense of claims asserting antitrust challenges to patent settlements, matters which led to the Supreme Court’s landmark Actavis decision.
Outside of litigation, Mr. Mach is often called upon for antitrust counseling and advice concerning regulatory inquiries, business transactions, and other issues. For example, Mr. Mach led the antitrust team advising Intel Corporation in its agreement to sell its NAND flash memory solid state drive and wafer businesses to SK Hynix, a South Korean semiconductor manufacturer, for $9 billion USD. He has also advised clients facing regulatory inquiries in many foreign jurisdictions, such as the European Union, Japan, South Korea, Singapore, Taiwan, Brazil, the United Kingdom and Australia.
Prior to joining Munger Tolles, Mr. Mach was associated with Cravath, Swaine & Moore LLP in New York City and was a law clerk to the Honorable Ronald M. Gould on the U.S. Court of Appeals for the Ninth Circuit in Seattle.
Mr. Mach graduated magna cum laude in 2006 from the University of Pennsylvania Law School, where he won the university's highest moot court competition and was also given the prize for the year’s best individual moot court performance.